IL105145A0 - Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection - Google Patents
Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infectionInfo
- Publication number
- IL105145A0 IL105145A0 IL105145A IL10514593A IL105145A0 IL 105145 A0 IL105145 A0 IL 105145A0 IL 105145 A IL105145 A IL 105145A IL 10514593 A IL10514593 A IL 10514593A IL 105145 A0 IL105145 A0 IL 105145A0
- Authority
- IL
- Israel
- Prior art keywords
- hiv
- prevention
- treatment
- monoclonal antibodies
- recombinant human
- Prior art date
Links
- 208000031886 HIV Infections Diseases 0.000 title 1
- 208000037357 HIV infectious disease Diseases 0.000 title 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86170192A | 1992-04-01 | 1992-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL105145A0 true IL105145A0 (en) | 1993-07-08 |
Family
ID=25336532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL105145A IL105145A0 (en) | 1992-04-01 | 1993-03-24 | Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0577243A3 (en) |
| JP (1) | JPH06217791A (en) |
| KR (1) | KR950700761A (en) |
| CN (1) | CN1081716A (en) |
| AU (2) | AU3928593A (en) |
| BG (1) | BG99074A (en) |
| CA (1) | CA2093099A1 (en) |
| CZ (1) | CZ239694A3 (en) |
| FI (1) | FI944561A (en) |
| HU (1) | HUT70461A (en) |
| IL (1) | IL105145A0 (en) |
| MX (1) | MX9301858A (en) |
| NO (1) | NO943653L (en) |
| NZ (1) | NZ251582A (en) |
| RU (1) | RU94045907A (en) |
| SK (1) | SK116294A3 (en) |
| WO (1) | WO1993019785A1 (en) |
| YU (1) | YU22693A (en) |
| ZA (1) | ZA932308B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69938435D1 (en) * | 1998-10-30 | 2008-05-08 | Novozymes As | Low allergenic protein variants |
| RU2221873C2 (en) * | 2001-04-24 | 2004-01-20 | Закрытое акционерное общество "АСГЛ-Фармацевтические Инновации" | Method for preparing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| US7560529B2 (en) | 2001-04-24 | 2009-07-14 | FDS Pharma | Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| FR2844455B1 (en) * | 2002-09-13 | 2007-12-14 | Lab Francais Du Fractionnement | TREATMENT OF PATHOLOGIES EXCLUDING IMMUNE RESPONSE BY OPTIMIZED ANTIBODIES |
| PT1595959E (en) * | 2003-02-20 | 2015-03-05 | Chemo Sero Therapeut Res Inst | Method for enhancing efficacy of a monoclonal antibody preparation |
| BRPI0815743A2 (en) * | 2007-08-24 | 2015-02-18 | Novartis Ag | HIV ENV PROTEINS WITH LOOP MODIFICATIONS |
| PT2364314E (en) | 2008-12-09 | 2014-06-09 | Gilead Sciences Inc | Modulators of toll-like receptors |
| WO2015117008A2 (en) | 2014-01-31 | 2015-08-06 | The Rockefeller University | Broadly neutralizing anti-hiv antibodies and epitope therefor |
| CN106714800B (en) | 2014-07-11 | 2021-09-03 | 吉利德科学公司 | TOLL-like receptor modulators for the treatment of HIV |
| BR102015023450A2 (en) | 2014-09-16 | 2016-04-12 | Gilead Sciences Inc | solid forms of a toll-like receptor modulator |
| WO2021227138A1 (en) * | 2020-05-09 | 2021-11-18 | 江苏省疾病预防控制中心(江苏省公共卫生研究院) | Monoclonal antibody for novel coronavirus, or antigen binding part thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE122237T1 (en) * | 1987-05-29 | 1995-05-15 | Tanox Biosystems Inc | HIV-1 NEUTRALIZING MONOCLONAL ANTIBODIES. |
| EP0311228A3 (en) * | 1987-10-09 | 1990-05-02 | Repligen Corporation | Recombinant polypeptides and their uses, including assay for aids virus |
| JPH05506561A (en) * | 1989-06-05 | 1993-09-30 | レプリゲン・コーポレーション | HIV-1 MN gp120 human monoclonal antibody |
| CA2087347C (en) * | 1990-06-15 | 2004-03-30 | Susan Zolla-Pazner | Heterohybridomas producing human monoclonal antibodies to hiv-1 |
| CA2128879A1 (en) * | 1992-01-29 | 1993-08-05 | Marie E. Beckner | Aamp-1, a protein with local homologies to hiv-1 env and nef proteins |
-
1993
- 1993-03-23 AU AU39285/93A patent/AU3928593A/en not_active Abandoned
- 1993-03-23 NZ NZ251582A patent/NZ251582A/en unknown
- 1993-03-23 WO PCT/US1993/002629 patent/WO1993019785A1/en not_active Application Discontinuation
- 1993-03-23 HU HU9402824A patent/HUT70461A/en unknown
- 1993-03-23 RU RU94045907/13A patent/RU94045907A/en unknown
- 1993-03-23 CZ CZ942396A patent/CZ239694A3/en unknown
- 1993-03-23 SK SK1162-94A patent/SK116294A3/en unknown
- 1993-03-24 IL IL105145A patent/IL105145A0/en unknown
- 1993-03-31 MX MX9301858A patent/MX9301858A/en unknown
- 1993-03-31 AU AU35630/93A patent/AU658987B2/en not_active Ceased
- 1993-03-31 CA CA002093099A patent/CA2093099A1/en not_active Abandoned
- 1993-03-31 CN CN93105210A patent/CN1081716A/en active Pending
- 1993-03-31 ZA ZA932308A patent/ZA932308B/en unknown
- 1993-03-31 EP EP9393302546A patent/EP0577243A3/en not_active Ceased
- 1993-04-01 JP JP5098474A patent/JPH06217791A/en active Pending
- 1993-04-01 YU YU22693A patent/YU22693A/en unknown
-
1994
- 1994-09-28 BG BG99074A patent/BG99074A/en unknown
- 1994-09-30 FI FI944561A patent/FI944561A/en unknown
- 1994-09-30 KR KR1019940703497A patent/KR950700761A/en not_active Application Discontinuation
- 1994-09-30 NO NO943653A patent/NO943653L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3928593A (en) | 1993-11-08 |
| HUT70461A (en) | 1995-10-30 |
| SK116294A3 (en) | 1996-11-06 |
| BG99074A (en) | 1995-11-30 |
| JPH06217791A (en) | 1994-08-09 |
| FI944561A0 (en) | 1994-09-30 |
| HU9402824D0 (en) | 1994-11-28 |
| EP0577243A3 (en) | 1994-11-02 |
| KR950700761A (en) | 1995-02-20 |
| CZ239694A3 (en) | 1995-07-12 |
| AU3563093A (en) | 1993-10-07 |
| AU658987B2 (en) | 1995-05-04 |
| MX9301858A (en) | 1994-03-31 |
| EP0577243A2 (en) | 1994-01-05 |
| RU94045907A (en) | 1996-11-10 |
| ZA932308B (en) | 1994-09-30 |
| NZ251582A (en) | 1997-07-27 |
| YU22693A (en) | 1997-01-08 |
| WO1993019785A1 (en) | 1993-10-14 |
| NO943653L (en) | 1994-11-30 |
| FI944561A (en) | 1994-09-30 |
| CA2093099A1 (en) | 1993-10-02 |
| CN1081716A (en) | 1994-02-09 |
| NO943653D0 (en) | 1994-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0831873A4 (en) | The treatment of hiv and other viral infections using combinatory therapy | |
| ZA917170B (en) | Novel antibodies for treatment and prevention of infection in animals and man | |
| ZA896864B (en) | Method and composition for the treatment and prevention of viral infections | |
| EP0584558A3 (en) | A composition for suppressing infection and growth of human immunodeficiency virus using an iron-binding protein. | |
| ZA932445B (en) | Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man | |
| KR890002547A (en) | Monoclonal antibodies and peptides for the treatment and diagnosis of HIV infection | |
| AU4028895A (en) | Vaccine and treatment method of Human Immunodeficiency Virus | |
| IL105145A0 (en) | Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection | |
| EP0531365A4 (en) | Diagnosis and treatment of viral hepatitis | |
| GB9304746D0 (en) | Treatment of viral infections | |
| EP0628056A4 (en) | Directed human immune globulin for the prevention and treatment of staphylococcal infections. | |
| ZA9510108B (en) | Composition and method for prevention and treatment of HIV-1 infection | |
| EP0382551A3 (en) | Prevention and treatment of herpes virus infections | |
| AU591017B2 (en) | Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient | |
| ZA946489B (en) | Novel treatment of upper respiratory tract infections | |
| EP0655919A4 (en) | Treatment of human viral infections. | |
| IL102815A0 (en) | Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus | |
| GB9216360D0 (en) | Treatment of blood | |
| NO960551D0 (en) | Antibody based treatment of HIV infection | |
| LTIP472A (en) | Composition for the treatment of infection and disease caused by hepatit b virus | |
| PH27412A (en) | Method of treatment of human immunodeficiency virus | |
| ZA941471B (en) | Treatment of viral infections | |
| IE880770L (en) | Treatment of viral infections | |
| NZ231322A (en) | Treatment of viral and/or bacterial infections | |
| NZ233973A (en) | Treatment of viral and/or bacterial infections |